These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26475480)

  • 21. 2016 in review: FDA approvals of new molecular entities.
    Griesenauer RH; Kinch MS
    Drug Discov Today; 2017 Nov; 22(11):1593-1597. PubMed ID: 28687460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rise of micropharma.
    Barden CJ; Weaver DF
    Drug Discov Today; 2010 Feb; 15(3-4):84-7. PubMed ID: 19837185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
    Beck A; Wurch T; Reichert JM
    MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming the obstacles in the pharma/biotech industry: 2009 update.
    Graul AI; Revel L; Tell M; Rosa E; Cruces E
    Drug News Perspect; 2010; 23(1):48-63. PubMed ID: 20155219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partnership between small biotech and big pharma.
    Wiederrecht GJ; Hill RG; Beer MS
    IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018.
    Graul AI; Dulsat C; Pina P; Cruces E; Tracy M
    Drugs Today (Barc); 2019 Feb; 55(2):131-160. PubMed ID: 30816887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Drug Discovery and Development Industry in India-Two Decades of Proprietary Small-Molecule R&D.
    Differding E
    ChemMedChem; 2017 Jun; 12(11):786-818. PubMed ID: 28464443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pharma-biotech company formation in India.
    Saberwal G
    Nat Biotechnol; 2006 May; 24(5):499-501. PubMed ID: 16680124
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical R&D performance by firm size: approval success rates and economic returns.
    DiMasi JA
    Am J Ther; 2014; 21(1):26-34. PubMed ID: 23344103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shaking Up Biotech/Pharma: Can Cues Be Taken from the Tech Industry?
    Wang CK
    SLAS Technol; 2017 Jun; 22(3):233-236. PubMed ID: 28298148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deal watch: Biopharma deal-making in 2015: changing the pharma landscape.
    Micklus A; Muntner S
    Nat Rev Drug Discov; 2016 Feb; 15(2):78-9. PubMed ID: 26837586
    [No Abstract]   [Full Text] [Related]  

  • 33. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
    BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanobiotech in big pharma: a business perspective.
    Würmseher M; Firmin L
    Nanomedicine (Lond); 2017 Mar; 12(5):535-543. PubMed ID: 28178881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sources of innovation: an assessment of intellectual property.
    Kinch MS; Raffo J
    Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The year's new drugs & biologics, 2017, part II - News that shaped the industry in 2017.
    Graul AI; Dulsat C; Pina P; Tracy M; D'Souza P
    Drugs Today (Barc); 2018 Feb; 54(2):137-167. PubMed ID: 29637939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Added Value - but Many Stumbling Blocks along the Way NTN Biotech Identifies where the Shoe Pinches.
    Heinzelmann E
    Chimia (Aarau); 2016; 70(1-2):118-20. PubMed ID: 26931230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The year's new drugs & biologics, 2013: Part II.
    Graul AI; Navarro D; Dulsat C; Cruces E; Tracy M
    Drugs Today (Barc); 2014 Feb; 50(2):133-58. PubMed ID: 24619590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of pharma R&D productivity - a new perspective needed.
    Schuhmacher A; Hinder M; von Stegmann Und Stein A; Hartl D; Gassmann O
    Drug Discov Today; 2023 Oct; 28(10):103726. PubMed ID: 37506762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.